ArticleOncotarget2016

Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.